Recent Transactions by Orion Corporation’s Senior Manager
Overview of Managerial Transactions at Orion Corporation
Orion Corporation has recently disclosed important information regarding managerial transactions. This relates specifically to actions taken by key individuals within the company, adhering to the standards set forth by Market Abuse Regulation (EU) No 596/2014. The most notable transaction comes from Julia Macharey, who is recognized as a senior manager at Orion.
Details of the Notification
Orion Corporation has filed an initial notification concerning transactions involving shares and linked securities, specifically outlining Julia Macharey’s trading activity. The issuer of this notification is Orion Oyj, and it carries a reference number of 99441/5/4. The Legal Entity Identifier (LEI) linked to this notification is 74370029VAHCXDR7B745, providing a robust framework for tracking such transactions.
Key Transaction Information
On March 10, a notable transaction occurred outside a trading venue where Julia Macharey participated in receiving a share-based incentive. This transaction involved:
- Transaction Date: March 10
- Instrument Type: Share
- ISIN: FI0009014377
- Volume: 7,356 shares
- Unit Price: 0 EUR
Aggregated Transaction Summary
The aggregated transaction of shares reported by Orion Corporation also reflected a volume of 7,356 shares, with a volume-weighted average price of zero. This indicates that the shares involved in this incentive scheme may not have been purchased outright but awarded as part of a compensation package.
Company Insights
Orion Corporation has established itself as a pillar in the pharmaceutical sector, contributing to well-being for over a century. It is a Finnish company known for developing, manufacturing, and marketing both human and veterinary pharmaceuticals, alongside active pharmaceutical ingredients.
Core Areas of Focus
Orion has built an impressive portfolio that spans proprietary and generic medicines as well as consumer health products. Notably, the company zeros in on significant therapeutic areas within its pharmaceutical research and development, with a strong emphasis on oncology and pain management. Their proprietary products are specifically designed to combat serious health challenges, such as cancer, neurological diseases, and respiratory conditions.
Financial Performance and Workforce
In the previous year, Orion reported net sales reaching EUR 1,542 million, reflecting the company’s robust market position and its commitment to delivering high-quality healthcare solutions. As of the end of 2024, Orion had a workforce comprising approximately 3,700 dedicated employees working towards the company's mission.
Contact Information
For further inquiries regarding the managerial transactions or other corporate communications, you may reach out to Orion Corporation at:
Orion Corporation Communications
Orionintie 1A, FI-02200, Espoo, Finland
Frequently Asked Questions
What was the nature of Julia Macharey’s transaction?
The transaction involved the receipt of a share-based incentive, reflecting the company’s compensation strategy.
What is Orion Corporation known for?
Orion Corporation is a Finnish pharmaceutical company focused on developing human and veterinary medicines, particularly in oncology and pain management.
How can I get in touch with Orion Corporation?
Contact Orion Corporation's Communications team at Orionintie 1A, FI-02200, Espoo, Finland for further information.
What are the key financial figures for Orion Corporation?
Orion Corporation reported net sales of EUR 1,542 million in 2024, showcasing its strong financial standing in the pharmaceutical market.
Where are Orion's shares listed?
The shares of Orion Corporation are listed on Nasdaq Helsinki, providing a platform for investors to trade their stock.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.